Calculus Capital

1-2 of 2 Articles
Clock icon 2 minutes

Invizius, an Edinburgh-based biotech company pioneering treatments for dialysis patients, has secured £950,000 in funding. The funding round was led by Mercia Ventures and supported by Calculus Capital, Syensqo, the University of Edinburgh's Old College Capital, and Scottish Enterprise.

1-2 of 2 Articles
Intership icon

Latest Jobs

Intership icon

Latest Events